scholarly journals Simple and Rapid Method for Wogonin Preparation and Its Biotransformation

2021 ◽  
Vol 22 (16) ◽  
pp. 8973
Author(s):  
Tomasz Tronina ◽  
Monika Mrozowska ◽  
Agnieszka Bartmańska ◽  
Jarosław Popłoński ◽  
Sandra Sordon ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Phase Ii Metabolism ◽  
Major Phase ◽  
Chinese Medicines ◽  
Scutellaria Baicalensis Georgi ◽  
Health Promoting ◽  
The One ◽  
Therapeutic Activities ◽  
Scale Transformations

Wogonin is one of the most active flavonoids from Scutellaria baicalensis Georgi (baikal skullcap), widely used in traditional Chinese medicine. It exhibits a broad spectrum of health-promoting and therapeutic activities. Together with baicalein, it is considered to be the one of main active ingredients of Chinese medicines for the management of COVID-19. However, therapeutic use of wogonin may be limited due to low market availability connected with its low content in baikal skullcap and lack of efficient preparative methods for obtaining this compound. Although the amount of wogonin in skullcap root often does not exceed 0.5%, this material is rich in wogonin glucuronide, which may be used as a substrate for wogonin production. In the present study, a rapid, simple, cheap and effective method of wogonin and baicalein preparation, which provides gram quantities of both flavonoids, is proposed. The obtained wogonin was used as a substrate for biotransformation. Thirty-six microorganisms were tested in screening studies. The most efficient were used in enlarged scale transformations to determine metabolism of this xenobiotic. The major phase I metabolism product was 4’-hydroxywogonin—a rare flavonoid which exhibits anticancer activity—whereas phase II metabolism products were glucosides of wogonin. The present studies complement and extend the knowledge on the effect of substitution of A- and B-ring on the regioselective glycosylation of flavonoids catalyzed by microorganisms.

scholarly journals Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines

Cancers ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 404 ◽  
Author(s):  
Guo ◽  
Tan ◽  
Chen ◽  
Wang ◽  
Feng
Keyword(s):  
Chinese Medicine ◽  
Cancer Therapy ◽  
Traditional Chinese Medicine ◽  
Cancer Cells ◽  
Metabolic Pathways ◽  
Cancer Metabolism ◽  
Metabolic Reprogramming ◽  
Traditional Chinese Medicines ◽  
Chinese Medicines ◽  
Incidence And Mortality

Cancer is a common and complex disease with high incidence and mortality rates, which causes a severe public health problem worldwide. As one of the standard therapeutic approaches for cancer therapy, the prognosis and outcome of chemotherapy are still far from satisfactory due to the severe side effects and increasingly acquired resistance. The development of novel and effective treatment strategies to overcome chemoresistance is urgent for cancer therapy. Metabolic reprogramming is one of the hallmarks of cancer. Cancer cells could rewire metabolic pathways to facilitate tumorigenesis, tumor progression, and metastasis, as well as chemoresistance. The metabolic reprogramming may serve as a promising therapeutic strategy and rekindle the research enthusiasm for overcoming chemoresistance. This review focuses on emerging mechanisms underlying rewired metabolic pathways for cancer chemoresistance in terms of glucose and energy, lipid, amino acid, and nucleotide metabolisms, as well as other related metabolisms. In particular, we highlight the potential of traditional Chinese medicine as a chemosensitizer for cancer chemotherapy from the metabolic perspective. The perspectives of metabolic targeting to chemoresistance are also discussed. In conclusion, the elucidation of the underlying metabolic reprogramming mechanisms by which cancer cells develop chemoresistance and traditional Chinese medicines resensitize chemotherapy would provide us a new insight into developing promising therapeutics and scientific evidence for clinical use of traditional Chinese medicine as a chemosensitizer for cancer therapy.

scholarly journals Arsenic Bioaccessibility of Realgar Influenced by the Other Traditional Chinese Medicines in Niuhuang Jiedu Tablet and the Roles of Gut Microbiota

2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Wenfeng Xu ◽  
Shuo Xu ◽  
Shanshan Zhang ◽  
Xuejun Wu ◽  
Pengfei Jin
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Gut Microbiota ◽  
Incubation Medium ◽  
Toxic Elements ◽  
The Other ◽  
Traditional Chinese Medicines ◽  
Chinese Medicines ◽  
Scutellariae Radix

Niuhuang Jiedu tablet (NJT), a realgar (As2S2) containing Traditional Chinese Medicine (TCM), is a well-known formula. The safety of NJT is of growing concern since arsenic (As) is considered as one of the most toxic elements. NJT was demonstrated to be safer than realgar by our previous experiments and some other studies. The toxicity of realgar has been shown to be related to the amount of soluble or bioaccessible arsenic. In this study, the influences of the other TCMs in NJT on the bioaccessibility of arsenic from realgar, and the roles of gut microbiota during this process were investigated in vitro. Results showed that Dahuang (Rhei Radix et Rhizoma), Huangqin (Scutellariae Radix), Jiegeng (Platycodonis Radix), and Gancao (Glycyrrhizae Radix et Rhizoma) could significantly reduce the bioaccessibility of arsenic from realgar in artificial gastrointestinal fluids. Gut microbiota played an important role in decreasing the bioaccessibility of realgar because it was demonstrated to be able to absorb the soluble arsenic from realgar in the incubation medium. Dahuang, Huangqin, and Jiegeng could modulate the gut microbiota to enhance its arsenic absorption activity.

Hemagglutination Characterization of Lectins from Four Traditional Chinese Medicines

2013 ◽  
Vol 634-638 ◽  
pp. 1309-1312
Author(s):  
Hui Jun Yuan ◽  
Ai Mei Yang ◽  
Hui Ling Gong ◽  
Jing Hu ◽  
Jing Ting Bao ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Red Blood Cells ◽  
Blood Cells ◽  
Traditional Chinese Medicines ◽  
Chinese Medicines ◽  
Hemagglutination Titer

Hemagglutination titer of crude lectin from four traditional chinese medicine was detected. Lectins from Radix Polygalae and Saxifraga stolonifera agglutinated red blood cells of rabbit, rat and chook potently. Heteropappus hispidus (Thunb.) Less lectin also agglutinated the three kinds of red blood cells, but hemagglutination titer was lower. Hemagglutination effect of Lepisorus waltonii (Ching) Ching lectin only appeared in rat red blood cells.

Effects of Traditional Chinese Medicines on Murine Bone Metabolism in a Microgravity Environment

2003 ◽  
Vol 31 (05) ◽  
pp. 739-749 ◽  
Author(s):  
Qing-Hua Song ◽  
Takao Kobayashi ◽  
Takayuki Hosoi ◽  
Jong-Chol Cyong
Keyword(s):  
Alkaline Phosphatase ◽  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Bone Metabolism ◽  
Phosphatase Activity ◽  
Alkaline Phosphatase Activity ◽  
Space Environment ◽  
Microgravity Environment ◽  
Traditional Chinese Medicines ◽  
Chinese Medicines

We investigated the effects of three traditional Chinese medicine prescriptions on changes of bone metabolism in mice, using a gravity device to produce a microgravity environment. We found that Hochu-ekki-to (TJ-41) and Hachimi-jio-gan (TJ-7) suppress the increase in the ratio of serum Ca/P and the increase of calcium in urine. Moreover, TJ-41 and Shin-bu-to (TJ-30) reversed the increase of alkaline phosphatase activity (ALP), and TJ-41 also reversed the decrease of estradiol in the serum. The mechanism may be that the traditional Chinese medicines increased estradiol, causing the decrease of ALP, which induced the changes of Ca and P in serum, leading to a decreased excretion of Ca in urine. In this study, TJ-41 was effective in every parameter while TJ-7 and TJ-30 was effective on some parameters, showing that traditional Chinese medicines have specificities in the space environment. In conclusion, this study suggests that some traditional Chinese medicines may be beneficial for adaptation to a space environment.

The Application of High Throughput Microarrays in the Screening Active Ingredients of Traditional Chinese Medicine

2014 ◽  
Vol 998-999 ◽  
pp. 346-349
Author(s):  
Qing Shan Liu ◽  
Wei Wei Zhang ◽  
Xu Li ◽  
Shu Juan Zhuang ◽  
Xiao Ying Yin
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
High Throughput ◽  
Detection Method ◽  
Active Ingredients ◽  
Chinese Medicines ◽  
Accurate Detection ◽  
And Control ◽  
Research Tools

The accurate detection of traditional Chinese medicine is significant for diagnosis, treatment and control for disease. There is an urgent need for the development of a rapid, simple, and accurate detection method. The high throughput microarray is recommended for use in all researches including those involving rare samples and expensive reagents. Due to the complexity of Chinese medicines interference and multi-target, multi-component, the advantages that sensitivity, reproducibility, and specificity of high-throughput microarrays make it become one of the effective research tools.

THE FERMENTATION PROCESSING OF TRADITIONAL CHINESE MEDICINE: A SHORT REVIEW

2021 ◽  
pp. 48-51
Author(s):  
Saeed Hamid Saeed Omer ◽  
YUAN Yanzhi ◽  
LI Gaoqiang ◽  
LIU Yongli ◽  
GAO Wenlong ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Mode Of Action ◽  
Fermentation Process ◽  
Short Review ◽  
Traditional Chinese Medicines ◽  
Chinese Medicines ◽  
Fermentation Liquid ◽  
Solid Fermentation ◽  
Selection Of

In recent decades, the processing of traditional Chinese medicines has received widespread attention as people's requirements for safety and effectiveness of traditional Chinese medicine have increased. Because of its theory and technical methods, the fermentation processing of traditional Chinese medicines has been distinct from other methods. Based on generalized fermentation, the fermentation of traditional Chinese medicine is based on collection of appropriate traditional Chinese medicinal materials for processing according to the characteristics of the bacteria, so that the original properties of the medicinal materials are modied and the effectiveness is increased. Strong fermentation, liquid fermentation, and two-way solid fermentation are popular fermentation methods. Currently, the study of traditional Chinese medicine's fermentation process has drawn wide interest from academics. In the future, in order to open up new avenues for fermentation and production of traditional Chinese medicine, the selection of fermenting microorganisms and the mode of action of strains in the fermentation phase need to be examined in depth.

scholarly journals In silico identification of natural products from Traditional Chinese Medicine for cancer immunotherapy

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Chuipu Cai ◽  
Qihui Wu ◽  
Honghai Hong ◽  
Liying He ◽  
Zhihong Liu ◽  
...  
Keyword(s):  
Natural Products ◽  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Cancer Immunotherapy ◽  
Functional Enrichment ◽  
Literature Mining ◽  
Systems Pharmacology ◽  
Scutellaria Baicalensis Georgi

AbstractAdvances in immunotherapy have revolutionized treatments in many types of cancer. Traditional Chinese Medicine (TCM), which has a long history of clinical adjuvant application against cancer, is emerging as an important medical resource for developing innovative cancer treatments, including immunotherapy. In this study, we developed a quantitative and systems pharmacology-based framework to identify TCM-derived natural products for cancer immunotherapy. Specifically, we integrated 381 cancer immune response-related genes and a compound-target interaction network connecting 3273 proteins and 766 natural products from 66 cancer-related herbs based on literature-mining. Via systems pharmacology-based prediction, we uncovered 182 TCM-derived natural products having potential anti-tumor immune responses effect. Importantly, 32 of the 49 most promising natural products (success rate = 65.31%) are validated by multiple evidence, including published experimental data from clinical studies, in vitro and in vivo assays. We further identified the mechanism-of-action of TCM in cancer immunotherapy using network-based functional enrichment analysis. We showcased that three typical natural products (baicalin, wogonin, and oroxylin A) in Huangqin (Scutellaria baicalensis Georgi) potentially overcome resistance of known oncology agents by regulating tumor immunosuppressive microenvironments. In summary, this study offers a novel and effective systems pharmacology infrastructure for potential cancer immunotherapeutic development by exploiting the medical wealth of natural products in TCM.

scholarly journals The Traditional Chinese Medicine and Relevant Treatment for the Efficacy and Safety of Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

2017 ◽  
Vol 2017 ◽  
pp. 1-20 ◽  
Author(s):  
Zhao-feng Shi ◽  
Tie-bing Song ◽  
Juan Xie ◽  
Yi-quan Yan ◽  
Yong-ping Du
Keyword(s):  
Chinese Medicine ◽  
Traditional Chinese Medicine ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Control Group ◽  
Controlled Trials ◽  
Traditional Chinese Medicines ◽  
Efficacy And Safety ◽  
Chinese Medicines ◽  
Randomized Controlled

Background. Atopic dermatitis (AD) has become a common skin disease that requires systematic and comprehensive treatment to achieve adequate clinical control. Traditional Chinese medicines and related treatments have shown clinical effects for AD in many studies. But the systematic reviews and meta-analyses for them are lacking. Objective. The systematic review and meta-analysis based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement were conducted to evaluate the efficacy and safety of traditional Chinese medicines and related treatments for AD treatment. Methods. Randomized controlled trials (RCTs) were searched based on standardized searching rules in eight medical databases from the inception up to December 2016 and a total of 24 articles with 1,618 patients were enrolled in this meta-analysis. Results. The results revealed that traditional Chinese medicines and related treatments did not show statistical differences in clinical effectiveness, SCORAD amelioration, and SSRI amelioration for AD treatment compared with control group. However, EASI amelioration of traditional Chinese medicines and related treatments for AD was superior to control group. Conclusion. We need to make conclusion cautiously for the efficacy and safety of traditional Chinese medicine and related treatment on AD therapy. More standard, multicenter, double-blind randomized controlled trials (RCTs) of traditional Chinese medicine and related treatment for AD were required to be conducted for more clinical evidences providing in the future.

Sign in / Sign up

Export Citation Format

Share Document